Drug: entecavir

Manufacturer: misc

Route of Administration: Oral

Site of Care: Outpatient

Approved Indication: treatment of chronic hepatitis B virus infection in adults and children at least 2 years of age with evidence of active viral replication and either evidence of persistent elevations in serum aminotransferases (ALT or AST) or histologically active disease

Disease: chronic viral hepatitis B

Therapeutic Area: Infectious disease, Gastroenterology, Hepatology

Enrollment Form Link: N/A

Phone Number: N/A

Fax Number: N/A

Product Website: N/A